Editorial: Are Mitochondrial Therapeutics the Next Disruptor in Molecular Healthcare?

Benedict C. Albensi

doi:10.1007/s12035-023-03653-9

Editorial: Are Mitochondrial Therapeutics the Next Disruptor in Molecular Healthcare?

Benedict C. Albensi

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	6633-6635
Number of pages	3
Journal	Molecular Neurobiology
Volume	62
Issue number	6
DOIs	https://doi.org/10.1007/s12035-023-03653-9
State	Published - Sep 29 2023

ASJC Scopus Subject Areas

Neuroscience (miscellaneous)
Neurology
Cellular and Molecular Neuroscience

Disciplines

Pharmacy and Pharmaceutical Sciences

Access to Document

10.1007/s12035-023-03653-9

https://rdcu.be/edx4V

Cite this

@article{ff50c5e91ed841e7bc8eaaacf6215b7a,

title = "Editorial: Are Mitochondrial Therapeutics the Next Disruptor in Molecular Healthcare?",

author = "Albensi, \{Benedict C.\}",

year = "2023",

month = sep,

day = "29",

doi = "10.1007/s12035-023-03653-9",

language = "English",

volume = "62",

pages = "6633--6635",

journal = "Molecular Neurobiology",

issn = "0893-7648",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - Editorial

T2 - Are Mitochondrial Therapeutics the Next Disruptor in Molecular Healthcare?

AU - Albensi, Benedict C.

PY - 2023/9/29

Y1 - 2023/9/29

UR - https://www.scopus.com/pages/publications/85173005627

UR - https://www.scopus.com/pages/publications/85173005627#tab=citedBy

U2 - 10.1007/s12035-023-03653-9

DO - 10.1007/s12035-023-03653-9

M3 - Editorial

C2 - 37773083

AN - SCOPUS:85173005627

SN - 0893-7648

VL - 62

SP - 6633

EP - 6635

JO - Molecular Neurobiology

JF - Molecular Neurobiology

IS - 6

ER -

Editorial: Are Mitochondrial Therapeutics the Next Disruptor in Molecular Healthcare?

ASJC Scopus Subject Areas

Disciplines

Access to Document

Other files and links

Cite this